Nurix Therapeutics, Inc. (NRIX) ownership: insiders 1% · institutions 115% (13F 2026-03-31). Insider activity, 90 days: Routine (13 sales, 0 open-market buys). SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| BlackRock | 8925642.00 | $138.35M | 8.6% | 2026-03-31 |
| Redmile Group, LLC | 7732808.00 | $119.86M | 7.5% | 2026-03-31 |
| Vestal Point Capital, LP | 6500000.00 | $100.75M | 6.3% | 2026-03-31 |
| Deep Track Capital, LP | 6345244.00 | $98.35M | 6.1% | 2026-03-31 |
| Vanguard | 6265208.00 | $97.11M | 6.0% | 2026-03-31 |
| FMR (Fidelity) | 5541271.00 | $85.89M | 5.3% | 2026-03-31 |
| State Street | 5141195.00 | $79.69M | 5.0% | 2026-03-31 |
| Morgan Stanley | 4931999.00 | $76.45M | 4.8% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-05 | |
| Sell | null | 2026-08-05 | |
| Sell | null | 2026-08-05 | |
| Sell | null | 2026-08-04 | |
| Sell | null | 2026-08-04 | |
| Sell | null | 2026-08-04 | |
| Sell | null | 2026-08-04 | |
| Sell | null | 2026-08-03 |
Back to NRIX overview · NRIX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.